DataKnowledgeCloudtrainingcoordination

Hepatitis C, Chronic (Disease Or Phenotype)

Nci:C197873

Msh:D019698

Mondo:MONDO:5354

Medcin:MEDCIN:38272

Mdr:MDR:10008912

Id:39ba23d3-4957-5b9b-bc47-fade40f432fb

Icpc2icd10eng:MTHU034339

Icd10cm:B18.2

Efo:EFO:4220

Chv:CHV:38367

Results found

Linked to

	Label	Description
	Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)- indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Vaniprevir indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Voxilaprevir indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pibrentasvir indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ombitasvir indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cycloprop(d)indolo(2,1-a)(2)benzazepine-9-carboxamide, 12-cyclohexyl-N-((dimethylamino)sulfonyl)-4b,5,5a,6-tetrahydro-3-methoxy-5a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)-, (4bS,5aR)- indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Velpatasvir indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Paritaprevir indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide indication Hepatitis C, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)- indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Vaniprevir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Voxilaprevir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Pibrentasvir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ombitasvir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Cycloprop(d)indolo(2,1-a)(2)benzazepine-9-carboxamide, 12-cyclohexyl-N-((dimethylamino)sulfonyl)-4b,5,5a,6-tetrahydro-3-methoxy-5a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)-, (4bS,5aR)- indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Velpatasvir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Paritaprevir indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide indication Hepatitis C, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.